Charles Schwab’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $179M | Sell |
639,261
-6,874
| -1% | -$1.81M | 0.02% | 501 |
|
|
2026
Q1 | $172M | Buy |
646,135
+5,576
| +0.9% | +$1.51M | 0.03% | 476 |
|
|
2025
Q4 | $161M | Sell |
640,559
-10,421
| -2% | -$2.77M | 0.03% | 496 |
|
|
2025
Q3 | $187M | Sell |
650,980
-23,177
| -3% | -$6.21M | 0.03% | 426 |
|
|
2025
Q2 | $177M | Buy |
674,157
+39,380
| +6% | +$9.59M | 0.03% | 440 |
|
|
2025
Q1 | $148M | Buy |
634,777
+35,226
| +6% | +$8.55M | 0.03% | 475 |
|
|
2024
Q4 | $137M | Buy |
599,551
+50,165
| +9% | +$11.5M | 0.03% | 508 |
|
|
2024
Q3 | $123M | Buy |
549,386
+12,145
| +2% | +$2.67M | 0.02% | 554 |
|
|
2024
Q2 | $109M | Buy |
537,241
+14,150
| +3% | +$2.88M | 0.02% | 603 |
|
|
2024
Q1 | $114M | Buy |
523,091
+4,964
| +1% | +$1.09M | 0.03% | 542 |
|
|
2023
Q4 | $118M | Sell |
518,127
-3,706
| -0.7% | -$779K | 0.03% | 486 |
|
|
2023
Q3 | $105M | Sell |
521,833
-61,653
| -11% | -$13M | 0.03% | 481 |
|
|
2023
Q2 | $121M | Buy |
583,486
+8,720
| +2% | +$1.69M | 0.03% | 443 |
|
|
2023
Q1 | $113M | Buy |
574,766
+11,156
| +2% | +$2.3M | 0.03% | 452 |
|
|
2022
Q4 | $114M | Sell |
563,610
-8,834
| -2% | -$1.73M | 0.04% | 433 |
|
|
2022
Q3 | $101M | Buy |
572,444
+8,253
| +1% | +$1.69M | 0.04% | 440 |
|
|
2022
Q2 | $114M | Buy |
564,191
+5,338
| +1% | +$1.14M | 0.04% | 404 |
|
|
2022
Q1 | $127M | Buy |
558,853
+8,798
| +2% | +$2.07M | 0.04% | 428 |
|
|
2021
Q4 | $148M | Buy |
550,055
+11,728
| +2% | +$2.9M | 0.04% | 387 |
|
|
2021
Q3 | $130M | Buy |
538,327
+9,951
| +2% | +$2.51M | 0.04% | 393 |
|
|
2021
Q2 | $125M | Buy |
528,376
+13,840
| +3% | +$3.15M | 0.04% | 408 |
|
|
2021
Q1 | $113M | Buy |
514,536
+13,382
| +3% | +$2.69M | 0.04% | 402 |
|
|
2020
Q4 | $87.6M | Buy |
501,154
+4,998
| +1% | +$863K | 0.03% | 469 |
|
|
2020
Q3 | $80.3M | Sell |
496,156
-35,704
| -7% | -$5.66M | 0.04% | 424 |
|
|
2020
Q2 | $75.9M | Buy |
531,860
+1,687
| +0.3% | +$233K | 0.04% | 448 |
|
|
2020
Q1 | $57.6M | Buy |
530,173
+5,855
| +1% | +$844K | 0.03% | 470 |
|
|
2019
Q4 | $76.2M | Buy |
524,318
+6,138
| +1% | +$886K | 0.04% | 426 |
|
|
2019
Q3 | $74.8M | Buy |
518,180
+14,462
| +3% | +$2.11M | 0.04% | 399 |
|
|
2019
Q2 | $74.8M | Buy |
503,718
+16,049
| +3% | +$2.24M | 0.05% | 390 |
|
|
2019
Q1 | $64.1M | Buy |
487,669
+9,210
| +2% | +$1.13M | 0.04% | 426 |
|
|
2018
Q4 | $51.9M | Buy |
478,459
+9,175
| +2% | +$1.23M | 0.04% | 432 |
|
|
2018
Q3 | $70M | Buy |
469,284
+16,388
| +4% | +$2.49M | 0.05% | 384 |
|
|
2018
Q2 | $69.9M | Buy |
452,896
+3,537
| +0.8% | +$534K | 0.05% | 362 |
|
|
2018
Q1 | $62.4M | Buy |
449,359
+23,697
| +6% | +$3.48M | 0.05% | 370 |
|
|
2017
Q4 | $58.3M | Buy |
425,662
+23,131
| +6% | +$3.06M | 0.05% | 390 |
|
|
2017
Q3 | $52.2M | Buy |
402,531
+12,002
| +3% | +$1.6M | 0.05% | 394 |
|
|
2017
Q2 | $51.7M | Buy |
390,529
+23,023
| +6% | +$2.82M | 0.05% | 381 |
|
|
2017
Q1 | $45.3M | Buy |
367,506
+11,570
| +3% | +$1.37M | 0.05% | 394 |
|
|
2016
Q4 | $39.3M | Buy |
355,936
+17,574
| +5% | +$1.95M | 0.04% | 410 |
|
|
2016
Q3 | $40M | Buy |
338,362
+4,114
| +1% | +$485K | 0.05% | 385 |
|
|
2016
Q2 | $37.4M | Buy |
334,248
+5,253
| +2% | +$565K | 0.05% | 392 |
|
|
2016
Q1 | $33.1M | Buy |
328,995
+16,102
| +5% | +$1.54M | 0.04% | 410 |
|
|
2015
Q4 | $33.2M | Buy |
312,893
+5,690
| +2% | +$587K | 0.04% | 394 |
|
|
2015
Q3 | $28.6M | Buy |
307,203
+2,878
| +0.9% | +$298K | 0.04% | 417 |
|
|
2015
Q2 | $31.7M | Buy |
304,325
+6,255
| +2% | +$651K | 0.04% | 410 |
|
|
2015
Q1 | $32.3M | Buy |
298,070
+56,187
| +23% | +$5.78M | 0.05% | 404 |
|
|
2014
Q4 | $22.4M | Buy |
241,883
+7,927
| +3% | +$700K | 0.03% | 486 |
|
|
2014
Q3 | $20.5M | Buy |
233,956
+3,609
| +2% | +$326K | 0.03% | 482 |
|
|
2014
Q2 | $20.3M | Buy |
230,347
+5,930
| +3% | +$514K | 0.03% | 483 |
|
|
2014
Q1 | $18.9M | Buy |
224,417
+3,633
| +2% | +$290K | 0.03% | 485 |
|
|
2013
Q4 | $17.3M | Buy |
220,784
+7,543
| +4% | +$643K | 0.03% | 478 |
|
|
2013
Q3 | $18.1M | Buy |
213,241
+4,472
| +2% | +$377K | 0.04% | 436 |
|
|
2013
Q2 | $18M | Buy |
+208,769
| New | +$17.3M | 0.04% | 408 |
|
Other funds holding LH
Charles Schwab's LH Position: Q2 2026 in Review
Charles Schwab reduced its Labcorp (LH) stake by 1.1% in Q2 2026, selling an estimated $1.81M and leaving 639,261 shares worth $179M. The position accounts for 0.02% of the portfolio, ranked #501.
Charles Schwab first reported a position in LH in Q2 2013 and has held it in 53 quarters since. The position peaked at $187M in Q3 2025. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Charles Schwab held 639,261 shares of Labcorp worth $179M as of Q2 2026.
- Charles Schwab sold 6,874 Labcorp shares in Q2 2026, an estimated $1.81M.
- Labcorp made up 0.02% of Charles Schwab's portfolio in Q2 2026, its #501 holding.
- Charles Schwab first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Labcorp position peaked at $187M in Q3 2025.
- 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.